Evolus

NASDAQ EOLS
$12.77 0.16 1.25%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 23 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

750.84M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

809.74M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

2.40
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

58.80M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

21.27 %

Upcoming events Evolus

All events
No upcoming events scheduled

Stock chart Evolus

Stock analysis Evolus

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-12.51 8.79
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-36.29 25.38
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-22.23 4.40
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-1.62 0.50
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-325.34 9.54

Price change Evolus per year

2.85$ 17.38$
Min Max

Summary analysis Evolus

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Evolus

Revenue and net income Evolus

All parameters

About company Evolus

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was founded in 2012 and is headquartered in Newport Beach, California.
Address:
520 Newport Center Drive, Newport Beach, CA, United States, 92660
Company name: Evolus
Issuer ticker: EOLS
ISIN: US30052C1071
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2018-02-08
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.evolus.com

On which stock exchange are Evolus (EOLS) stocks traded?

Evolus (EOLS) stocks are traded on NASDAQ.

What is the ticker of Evolus stocks (EOLS)?

The stock ticker of Evolus’s stocks or in other words, the code is EOLS. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Evolus (EOLS) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Evolus (EOLS) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Evolus (EOLS) stocks traded?

Evolus (EOLS) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Evolus (EOLS) stocks today?

The current price of Evolus stocks on 15.05.2024 is 12.77 dollars. per share.

What is the dynamics of Evolus (EOLS) stocks from the beginning of the year?

Evolus (EOLS) quotes have increased by 27.83% from the beginning of the year up to 12.77 dollars. per 1 stocks.

How much did Evolus (EOLS) stocks increase in мае 2024?

This month Evolus (EOLS) quotes have increased by 1.19% to 12.77 dollars. per share.

How much are Evolus (EOLS) stocks worth?

Today, on October, 15.05.2024 Evolus’s (EOLS) stocks cost 12.77 dollars..

What is the market capitalization of Evolus (EOLS)?

Capitalization is the market value of Evolus (EOLS) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 15.05.2024, the market capitalization of Evolus (EOLS) is estimated at about 750841661 dollars.